Remel Haemophilus influenzae Agglutinating Sera - HSA Registration DE0016000
Access comprehensive regulatory information for Remel Haemophilus influenzae Agglutinating Sera in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0016000 and owned by Remel Europe Limited. The device was registered on July 17, 2014.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Haemophilus influenzae Agglutinating Sera are intended for use in the qualitative slide agglutination test and in counterimmunoelectrophoresis (CIE) to identify serologically the type antigen of pathogenic strains of H. influenzae (types a to f) for epidemiological and diagnostic purposes.